ZSCAN5A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.075200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.940800E-01
Normal-vs-Stage2
2.598400E-01
Normal-vs-Stage3
1.097950E-01
Normal-vs-Stage4
3.374000E-01
Stage1-vs-Stage2
1.146640E-01
Stage1-vs-Stage3
8.924000E-02
Stage1-vs-Stage4
2.763000E-01
Stage2-vs-Stage3
2.058600E-01
Stage2-vs-Stage4
4.303000E-01
Stage3-vs-Stage4
2.216000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.413400E-01
Normal-vs-AfricanAmerican
6.760400E-01
Normal-vs-Asian
1.578830E-01
Caucasian-vs-AfricanAmerican
6.117000E-01
Caucasian-vs-Asian
1.695620E-01
AfricanAmerican-vs-Asian
1.789370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.280000E-01
Normal-vs-Female
3.968800E-01
Male-vs-Female
8.808800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.711400E-01
Normal-vs-Age(41-60Yrs)
4.123000E-01
Normal-vs-Age(61-80Yrs)
4.233600E-01
Normal-vs-Age(81-100Yrs)
2.083800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.539400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.456000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.384000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.423000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.874200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.451400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.329600E-02
Normal-vs-Daily Drinker
3.901200E-01
Normal-vs-Weekly Drinker
2.359000E-01
Normal-vs-Occasional Drinker
8.893400E-01
Normal-vs-Social Drinker
2.327200E-01
Non Drinker-vs-Daily Drinker
2.064600E-01
Non Drinker-vs-Weekly Drinker
9.131800E-01
Non Drinker-vs-Occasional Drinker
2.734100E-02
Non Drinker-vs-Social Drinker
3.268000E-01
Daily Drinker-vs-Weekly Drinker
4.271400E-01
Daily Drinker-vs-Occasional Drinker
2.292200E-01
Daily Drinker-vs-Social Drinker
8.112600E-01
Weekly Drinker-vs-Occasional Drinker
9.357700E-02
Weekly Drinker-vs-Social Drinker
5.515800E-01
Occasional Drinker-vs-Social Drinker
1.760040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.757400E-01
Normal-vs-Grade 2
3.246600E-01
Normal-vs-Grade 3
2.569600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.228400E-02
Grade 1-vs-Grade 3
2.028800E-01
Grade 1-vs-Grade 4
2.757400E-01
Grade 2-vs-Grade 3
2.043800E-01
Grade 2-vs-Grade 4
3.246600E-01
Grade 3-vs-Grade 4
2.569600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.930380E-01
Normal-vs-NonDiabetic
3.895200E-01
Diabetic-vs-NonDiabetic
2.237800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.018500E-03
Normal-vs-NoPancreatitis
3.970800E-01
Pancreatitis-vs-NoPancreatitis
9.64700000000152E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.105000E-01
Normal-vs-N1
2.698000E-01
N0-vs-N1
2.496600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.152600E-01
Normal-vs-TP53-NonMutant
9.378400E-01
TP53-Mutant-vs-TP53-NonMutant
3.578300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
